Recall Register

Food, drugs, devices › Integra LifeSciences Corp.

Device recall: MAYFIELD¿ Composite Series Base Unit Standard, Model (A3101), Rx ONLY, Integra LifeScience Corporation, 4900 Charlemar D

FDA enforcement event 64185 · Class II · initiated 21 Dec 2012 · status Terminated · terminated 10 Jul 2013

DeviceVoluntary: Firm initiated1 product recordPlainsboro, NJ

FDA enforcement event 64185 is a device recall by Integra LifeSciences Corp. of Plainsboro, NJ, initiated 21 Dec 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 10 Jul 2013. Initiation: voluntary: firm initiated. Integra LifeSciences Corp. has 79 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Integra LifeSciences Corp., Plainsboro, NJ.

Reason for recall

"Integra determined there is a possibility that the Base Units may break during use."

Distribution

"Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA & WI. Internationally to Belgium."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0869-2013MAYFIELD¿ Composite Series Base Unit Standard, Model (A3101), Rx ONLY, Integra LifeScience Corporation, 4900 Charlemar Drive, Building A, Cincinnati, OH 45227 The MAYFIELD¿ Base Units are intended to be used to support a patient during diagnostic examination and/or surgical procedures where a rigid support between…96 unitsClass IITerminated27 Feb 2013

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
79events on this register for the firm

Other enforcement events for Integra LifeSciences Corp.

InitiatedProduct (first record)TypeClassRecords
6 Feb 2025AURORA Surgiscope System, Sterile, single use device that contains a Sheath, Obturator, and Imager. Manufacturer's ProduDeviceClass II1
10 Jan 2025Brand Name: MediHoney¿ Gel Product Name: MediHoney¿ Wound & Burn Dressing Gel Model/Catalog Number: 31815 Software VersiDeviceClass II1
16 Dec 2024CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Model Number: 828810 Implantable device that provides conDeviceClass II3
26 Sep 2024Duraform Dural Graft Implant, Size 3x3 , Model Number 80-1477US Lot CT007694DeviceClass II1
20 Sep 2024MICR PATIE RND Model/Catalog Number: 801396. CODMAN Surgical Patties and CODMAN Surgical Strips are manufactured of COTTDeviceClass II22
13 Sep 2024MEDIHONEY Dressing with Active Leptospermum Honey Wound and Burn Dressing W/APPLICATOR, 1.5oz tube (Model Number 31515) DeviceClass II1
9 Jul 2024TruDi NAV Suction, 0 Degrees; Model/Catalog Number: TDNS000Z. TruDi" NAV Suction Instruments are intended for use with tDeviceClass II1
7 Jun 2024AURORA Surgiscope System. Sterile, single use device that contains a Sheath, Obturator, and Imager.DeviceClass II1
29 May 2024CUSA Excel C2600 23KHz Straight Handpiece-Indicated for use in surgical procedures where fragmentation, emulsification aDeviceClass II1
7 May 2024CODMAN BACTISEAL EVD Catheter Set - Indicated for gaining access to the ventricles of the brain and can be used with dimDeviceClass II3

All 79 events for Integra LifeSciences Corp.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Integra determined there is a possibility that the Base Units may break during use."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA & WI. Internationally to Belgium."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 10 Jul 2013. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.